Tilray

TLRY

Market cap $894M

The Canadian cannabis sector enters December 2025 with renewed attention from both traders and long-term investors. Market conditions have remained unpredictable this year, yet several leading companies continue showing resilience and strategic progress. The industry still faces slower domestic growth, tighter financing conditions, and heavy price competition. However, many operators are building stronger platforms, expanding international footprints, and positioning themselves for potential U.S. policy shifts. As these developments unfold, Canadian cannabis stocks remain essential watchlist candidates heading into the new year.

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $0.78, moving 3.76% from the previous trading session.

Selling hemp-based products has been a way for Canadian cannabis companies to enter the U.S. market. The U.S. government, however, is closing loopholes, which will effectively ban nearly all of those products in a year.

Nearly six months ago, Tilray Brands (TLRY) stockholders approved a 1-for-10 reverse stock split. Now the cannabis firm has given a date it will take effect, and shares are tanking.

Shares of Tilray Brands, Inc. (NASDAQ:TLRY) were down 19% to $0.8310 after the company announced a reverse stock split.

Tilray will reverse split its stock 10-for-1 on Monday. The shares will resume trading Tuesday morning at a share price close to $8.

TLRY posts a strong quarter as Canadian cannabis revenues grow and market shares climb across key product categories.

U.S. stock futures were higher this morning, with the Dow futures gaining around 50 points on Friday.

Tilray stock price has attempted to rebound this week as it rose in the last three consecutive days. It rose to a high of $1.03 in New York, up from this month's low of $0.8740.

Common Stock Expected to Begin Trading on a Split-Adjusted Basis on December 2, 2025 Common Stock Expected to Begin Trading on a Split-Adjusted Basis on December 2, 2025